Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Kidney Disease Stage 1”

187 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 187 results

Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)Study completedNCT00249652
What this trial is testing

Transplant and Addiction Project (TAP) - 1

Who this might be right for
End Stage Liver DiseaseEnd Stage Renal DiseaseSubstance-Related Disorders
St. Luke's-Roosevelt Hospital Center 41
Testing effectiveness (Phase 2)Study completedNCT02218099
What this trial is testing

Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of ASP8232 in Subjects With Renal Impairment and in Type 2 Diabetes Mellitus Subjects With Chronic Kidney Disease

Who this might be right for
Healthy SubjectsPharmacokinetics of ASP8232Pharmacodynamics of ASP8232+2 more
Astellas Pharma Europe B.V. 55
Not applicableStudy completedNCT00677534
What this trial is testing

Role of Extrarenal 1-Alpha-Hydroxylase in Patients With End Stage Renal Disease

Who this might be right for
End-Stage Renal Disease
University of Kansas 7
Not applicableWithdrawnNCT00898612
What this trial is testing

Early Detection of Graft-Versus-Host Disease in Patients Undergoing a Donor Bone Marrow Transplant

Who this might be right for
Lymphoma
Mayo Clinic
Testing effectiveness (Phase 2)WithdrawnNCT05599815
What this trial is testing

Part 1 - A Clinical Trial in Patients With Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome

Who this might be right for
Nephrotic Syndrome
Aldeyra Therapeutics, Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT04580420
What this trial is testing

Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD

Who this might be right for
Primary Hyperoxaluria Type 1End Stage Renal Disease
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company 28
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06072326
What this trial is testing

DApagliflozin SC0062 and Prevention of Renal Injury; a Randomized Evaluation

Who this might be right for
Type 1 Diabetes Mellitus With Diabetic Nephropathy
University Medical Center Groningen 36
Early research (Phase 1)Study completedNCT01460134
What this trial is testing

CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers

Who this might be right for
CD27 Expressing B-cell Malignancies for Example Hodgkin's LymphomaChronic Lymphocytic LeukemiaMantle Cell Lymphoma+7 more
Celldex Therapeutics 90
Testing effectiveness (Phase 2)Study completedNCT03366337
What this trial is testing

Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX

Who this might be right for
IgA NephropathyCKD Associated With Type 1 DiabetesFocal Segmental Glomerulosclerosis+1 more
Biogen 103
Early research (Phase 1)Study completedNCT00003368
What this trial is testing

Irinotecan in Treating Patients With Solid Tumors or Lymphoma Who Have Abnormal Liver or Kidney Function or Who Have Received Radiation Therapy to the Pelvis

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT05099445
What this trial is testing

Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of INCB000928 in Participants With Impaired Renal Function and Hemodialysis

Who this might be right for
Renal ImpairmentHemodialysis
Incyte Corporation 48
Post-approval studies (Phase 4)Active Not RecruitingNCT05411744
What this trial is testing

One-month Latent Tuberculosis Treatment for Renal Transplant Candidates

Who this might be right for
Latent TuberculosisEnd Stage Renal DiseaseRenal Transplant Candidate for Right Kidney+1 more
Rutgers, The State University of New Jersey 25
Testing effectiveness (Phase 2)UnknownNCT01154387
What this trial is testing

Evaluating Safety and Efficacy of TOL101 Induction Versus Anti-Thymocyte Globulin to Prevent Kidney Transplant Rejection

Who this might be right for
End Stage Renal DiseaseRenal Transplant
Tolera Therapeutics, Inc 85
Large-scale testing (Phase 3)Study completedNCT00939445
What this trial is testing

Short Daily Hemodialysis and Online HDF: Which One is Better?

Who this might be right for
End Stage Renal Disease
Bangkok Metropolitan Administration Medical College and Vajira Hospital 10
Testing effectiveness (Phase 2)Ended earlyNCT01113801
What this trial is testing

A Study in Participants With Diabetic Kidney Disease

Who this might be right for
Diabetic Kidney DiseaseDiabetic NephropathyDiabetic Glomerulosclerosis
Eli Lilly and Company 417
Early research (Phase 1)Study completedNCT02581124
What this trial is testing

Study to Evaluate Effect of Lapatinib on Pharmacokinetics of JTZ-951 in Subjects With End-stage Renal Disease

Who this might be right for
Anemia of Chronic Kidney Disease
Akros Pharma Inc. 10
Early research (Phase 1)Study completedNCT03814005
What this trial is testing

Pevonedistat in People With Blood Cancers or Solid Tumors With Kidney or Liver Problems

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myelomonocytic, ChronicLeukemia, Myeloid, Acute+3 more
Takeda 17
Testing effectiveness (Phase 2)Looking for participantsNCT07231679
What this trial is testing

Investigate IGT-303 in Healthy Volunteers and Participants With Chronic Kidney Disease

Who this might be right for
Healthy VolunteersChronic Kidney Disease
Ingenia Therapeutics INC 94
Early research (Phase 1)Study completedNCT03947970
What this trial is testing

Study to Evaluate the Pharmacokinetics and Metabolism of [14C] CR845 (Difelikefalin) in Patients With End Stage Renal Disease on Hemodialysis and in Healthy Subjects

Who this might be right for
HemodialysisHealthy
Cara Therapeutics, Inc. 12
Load More Results